Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported

Digestive Diseases and Sciences

Volumn 61, Issue 9, 2016, Pages 2619-2626

  Card, Timothy R ^a   Langan, Sinéad M ^b   Chu, Thomas P C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Arthritis; Epidemiology; Inflammatory bowel diseases; Iritis; Pyoderma

Indexed keywords

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTHROPATHY; ARTICLE; ATRIAL FIBRILLATION; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ELECTRONIC HEALTH RECORD; ERYTHEMA NODOSUM; EXTRA INTESTINAL MANIFESTATION; FEMALE; HUMAN; HYPERTENSION; IATROGENIC DISEASE; INFLAMMATORY BOWEL DISEASE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIGRAINE; MULTIPLE SCLEROSIS; OSTEOARTHRITIS; POLLEN ALLERGY; PRIMARY MEDICAL CARE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; PYODERMA GANGRENOSUM; RHEUMATOID ARTHRITIS; RISK FACTOR; SACROILIITIS; SCLEROSING CHOLANGITIS; ULCERATIVE COLITIS; UVEITIS; VERY ELDERLY; YOUNG ADULT; CASE CONTROL STUDY; CHOLANGITIS, SCLEROSING; INFANT; INFLAMMATORY BOWEL DISEASES; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; NEWBORN; ODDS RATIO; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RHINITIS, ALLERGIC, SEASONAL; SPONDYLITIS, ANKYLOSING; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOLANGITIS, SCLEROSING; COHORT STUDIES; ERYTHEMA NODOSUM; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATORY BOWEL DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; ODDS RATIO; PSORIASIS; PYODERMA GANGRENOSUM; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC, SEASONAL; SACROILIITIS; SPONDYLITIS, ANKYLOSING; UVEITIS; YOUNG ADULT;

EID: 84981501573     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-016-4195-1     Document Type: Article

References (21)

1. Bernstein CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001;85:430–434.
2. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375:657–663. doi:10.1016/S0140-6736(09)61963-2.
3. Hammer B, Ashurst P, Naish J. Diseases associated with ulcerative colitis and Crohn’s disease. Gut. 1968;9:17–21. doi:10.1136/gut.9.1.17.
4. Acheson ED. An association between ulcerative colitis, regional enteritis, and ankylosing spondylitis. Q J Med. 1960;29:489–499. http://www.ncbi.nlm.nih.gov/pubmed/13681207.
5. Vavricka SR, Brun L, Ballabeni P, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110–119. doi:10.1038/ajg.2010.343.
6. Lakatos L, Pandur T, David G, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol. 2003;9:2300–2307. http://www.ncbi.nlm.nih.gov/pubmed/14562397. Accessed Jun 12, 2013.
7. Williams H, Walker D, Orchard TR. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep. 2008;10:597–605. http://www.ncbi.nlm.nih.gov/pubmed/19006617. Accessed Oct 9, 2013.
8. Bernstein CN, Blanchard JF, Rawsthorne P, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116–1122. doi:10.1111/j.1572-0241.2001.03756.x.
9. Alonso Farto JC, Arias IA, Lopez Longo FJ, et al. Clinical significance of abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondyloarthropathies. Eur J Nucl Med. 2000;27:1768–1773. doi:10.1007/s002590000393.
10. Ciccacci C, Biancone L, Di Fusco D, et al. TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2013;7:44–52. doi:10.1016/j.crohns.2012.02.020.
11. Langan SM, Groves RW, Card TR, et al. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol. 2012;132:2166–2170. doi:10.1038/jid.2012.130.
12. Lewis JD, Brensinger C, Bilker WB, et al. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf. 2002;11:211–218. doi:10.1002/pds.698.
13. Herrett E, Thomas SL, Schoonen WM, et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010;69:4–14. doi:10.1111/j.1365-2125.2009.03537.x.
14. Jick H, Terris BZ, Derby LE, et al. Further validation of information recorded on a general practitioner based computerized data resource in the united kingdom. Pharmacoepidemiol Drug Saf. 1992;1:347–349. doi:10.1002/pds.2630010607.
15. Cullinan E. Ulcerative colitis: clinical aspects. Br Med J. 1938;2:1351–1356. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211132/. Accessed Dec 2, 2013.
16. Steinberg VL, Storey G. Ankylosing spondylitis and chronic inflammatory lesions of the intestines. Br Med J. 1957;2:1157–1159. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1963013&tool=pmcentrez&rendertype=abstract. Accessed Dec 2, 2013.
17. Billson FA, De Dombal FT, Watkinson G, et al. Ocular complications of ulcerative colitis. Gut. 1967;8:102–106. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1552509&tool=pmcentrez&rendertype=abstract. Accessed Oct 14, 2013.
18. Christodoulou DK, Katsanos KH, Kitsanou M, et al. Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature. Dig Liver Dis. 2002;34:781–786.
19. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. III. Complications. Gut. 1964;5:1–22. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1552214&tool=pmcentrez&rendertype=abstract. Accessed May 30 2012.
20. Bernstein CN, Wajda A, Blanchard JF. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol. 2008;6:41–45. doi:10.1016/j.cgh.2007.09.016.
21. Gupta G, Gelfand JM, Lewis JD. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology. 2005;129:819–826.